VacciNEWS
VacciREVIEW
VacciTUTOR
VacciBOOKS
VacciNATION
VacciPROFILE
- FDA
- EMA
- WHO
VacciCALENDAR
VacciVIDEOS

VacciNEWS
VacciREVIEW
VacciTUTOR
VacciBOOKS
VacciNATION
VacciPROFILE
- FDA
- EMA
- WHO
VacciCALENDAR
VacciVIDEOS

Twitter LinkedIn Facebook

Africa

Togo

5 August, 2022

Add comment

1 min read

Outbreak	Date
Lassa fever	24 Mar 2022

Uganda

Somalia

Notify of

Label

Name*

Email*

Website

Label

Name*

Email*

Website

0 Comments

Inline Feedbacks

View all comments

Republic of Tanzania declares Marburg Virus Disease (MVD) Outbreak

On 21 March 2023, the Ministry of Health (MoH) of Republic of Tanzania declared an outbreak of Marburg virus disease (MVD) in Bukoba district, Kagera region, north western Tanzania. Cumulatively, eight confirmed cases...

30 March, 2023

3 min read

Africa Outbreak Countries Outbreak News

Equatorial Guinea confirms first Marburg virus disease outbreak

Equatorial Guinea has confirmed its first outbreak of the Marburg virus, a highly infectious and deadly disease similar to Ebola, following the deaths of at least nine people, the World Health Organization (WHO) said on...

15 February, 2023

2 min read

Africa Outbreak Countries Outbreak News

Malaria: Three-dose Plasmodium falciparum sporozoite (PfSPZ) vaccine shows safety, efficacy in Burkina Faso adults

A three-dose regimen of a whole-parasite vaccine against malaria – called Plasmodium falciparum sporozoite (PfSPZ) vaccine – demonstrated safety and efficacy when tested in adults living in Burkina Faso, West Africa...

12 January, 2023

4 min read

Terms & Conditions || Privacy Policy || Disclaimer || Imprint || Contacts ||

Subject to Creative Commons Licence (cc).

VacciNEWS
VacciREVIEW
VacciTUTOR
VacciBOOKS
VacciNATION
VacciPROFILE
- FDA
- EMA
- WHO
VacciCALENDAR
VacciVIDEOS

wpDiscuz

Togo

You may also like

Republic of Tanzania declares Marburg Virus Disease (MVD) Outbreak

Equatorial Guinea confirms first Marburg virus disease outbreak

Malaria: Three-dose Plasmodium falciparum sporozoite (PfSPZ) vaccine shows safety, efficacy in Burkina Faso adults